Tirzepatide Treatment and Associated Changes in β-Cell Function and Insulin Sensitivity in People With Obesity or Overweight With Prediabetes or Normoglycemia: A Post Hoc Analysis From the SURMOUNT-1 Trial.
- Journal:
- Diabetes Care
- Published:
- DOI:
- 10.2337/dc25-0763
- Affiliations:
- 4
- Authors:
- 10
| Institutions | Authors | Share |
|---|---|---|
| Lilly, United States of America (USA) | 0.70 | |
| Institute of Neuroscience (IN), CNR, Italy | 0.10 | |
| Institute of Clinical Physiology (IFC), CNR, Italy | 0.10 | |
| Amsterdam UMC, Netherlands | 0.10 |